Paroxetine Oral Tablets (Immediate-Release) Suppliers & Bulk Manufacturers
Available Forms: Oral Tablets (immediate-release)
Available Strengths: 10 mg, 20 mg, 30 mg, 40 mg
Reference Brands: US: Paxil®, Pexeva®, Brisdelle®; EU: Seroxat®, ParoMerck®, Paxetin®
Category: Antipsychotropic Drugs
Paroxetine Oral Tablets (immediate-release) is available in Oral Tablets (immediate-release) and strengths such as 10 mg, 20 mg, 30 mg, 40 mg. Sourced from GMP-certified and ISO-compliant manufacturers, this API meets global pharmacopeia standards (USP/EP/JP as applicable). Ideal for pharmaceutical formulation and commercial manufacturing, Paroxetine Oral Tablets (immediate-release) is supplied in bulk quantities with complete regulatory support including DMF, COA, and MSDS.
| Technical Specifications & Supply Details | |
|---|---|
| Lead Time | 7 to 60 days (depending on batch size & schedule) |
| MOQ | As per manufacturer’s batch size |
| COA | Available with every batch |
| Regulatory Dossier / DMF | Available upon request |
| Export Documentation | FSC, COA, Manufacturing License, Product Permission |
| Standards | IP, BP, USP |
| Certifications | WHO-GMP, EU-GMP, USFDA (as applicable) |
Paroxetine Oral Tablets (immediate-release) can be exported to over 30 countries across Asia, Africa, Europe, and Latin America. Flexible packaging, competitive pricing, and a verified supplier network make Pharmatradz a trusted sourcing partner for pharmaceutical companies and contract manufacturers worldwide.
The Trade Mark owner has been correctly identified under the heading Manufacturer / TM Owner as required by the Act.
Product Description: Paroxetine immediate-release tablets are FDA-approved in the USA for depression, panic disorder, OCD, PTSD, GAD, and social anxiety disorder. As a selective serotonin reuptake inhibitor (SSRI), it carries a Boxed Warning regarding increased risk of suicidal thoughts in adolescents and young adults. Regulatory oversight includes strict GMP compliance, labeling requirements, and pharmacovigilance obligations, including adverse event reporting. In the EU, paroxetine IR tablets are widely approved by national authorities and/or the EMA for similar indications. Regulatory submissions must include RMPs, PSURs, and quality documentation. Discover global suppliers and compliant dossiers at Pharmatradz.com.
Frequently Asked Questions
Related Products
Risperidone Long-Acting Injection
Strength: 12.5 mg, 25 mg, 37.5 mg, 50 mg vials/syringes
Form: Long-Acting Injection
Reference Brands: Risperdal Consta(US &EU)
View Details
Zuclopenthixol Ong-Acting Im Injection (Depot)
Strength: 200 mg/mL, 500 mg/mL
Form: Long-acting IM Injection (Depot)
Reference Brands: Clopixol Depot®(US)
View Details
Zuclopenthixol Short-Acting Intramuscular Injection
Strength: 50 mg/mL
Form: Short-acting Intramuscular Injection
Reference Brands: Clopixol-Acuphase®
View Details
Zuclopenthixol Tablets
Strength: 10 mg, 25 mg, 40 mg
Form: Oral Tablets
Reference Brands: Clopixol®(EU)
View DetailsQuick Response Guaranteed | Verified Suppliers